Skip to main content
logo
RegenLab USA, Inc. (RGNA)
RegenLab USA will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

RegenLab USA Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Year Ending
TTMDec '25 Dec '24
Cash & Equivalents
4.831.850.96
Cash & Cash Equivalents
4.831.850.96
Cash Growth
-92.69%-
Receivables
8.77.124.91
Inventory
6.268.036.98
Other Current Assets
2.551.882.2
Total Current Assets
22.3418.8715.04
Property, Plant & Equipment
-11.7811.09
Goodwill and Intangibles
-18.9815.12
Other Long-Term Assets
-3.353.14
Total Long-Term Assets
-34.129.35
Total Assets
-52.9744.39

Liabilities

Year Ending
TTMDec '25 Dec '24
Accounts Payable
-13.2110.13
Current Debt
-12.23.49
Other Current Liabilities
35.155.035.5
Total Current Liabilities
35.1530.4419.12
Long-Term Debt
-29.429.64
Other Long-Term Liabilities
-2.753.42
Total Long-Term Liabilities
-32.1533.06
Total Liabilities
-62.5952.19

Shareholders' Equity

Year Ending
TTMDec '25 Dec '24
Retained Earnings
--13.27-10.57
Comprehensive Income
-2.041.17
Shareholders' Equity
-9.75-9.62-7.8

Additional Metrics

Year Ending
TTMDec '25 Dec '24
Total Debt
40.0441.6133.13
Debt Growth
-25.58%-
Net Cash (Debt)
-35.22-39.76-32.18
Net Cash (Debt) Growth
---
Working Capital
-12.8-11.57-4.09